Treatment-Continuity of ADHD Compared Using Immediate-Release and Extended-Release MPH

Treatment-Continuity of ADHD Compared Using Immediate-Release and Extended-Release MPH

The continuity of methylphenidate (MPH) therapy for ADHD in young Medicaid beneficiaries (ages 6 to 17 years) treated with immediate-release (IR) or extended-release (ER) MPH formulations was compared in an analysis of statewide California Medicaid claims (2000-2003) conducted at Columbia University...

Full description

Bibliographic Details
Main Author: J Gordon Millichap
Format: Article
Language:English
Published: Pediatric Neurology Briefs Publishers 2005-07-01
Series:Pediatric Neurology Briefs
Subjects:
methylphenidate
immediate-release
extended-release
Online Access:https://www.pediatricneurologybriefs.com/articles/1264
id doaj-1d1e3c6a28214231a7787d5d9ae07940
record_format Article
spelling doaj-1d1e3c6a28214231a7787d5d9ae079402020-11-25T01:14:08ZengPediatric Neurology Briefs PublishersPediatric Neurology Briefs1043-31552166-64822005-07-01197525210.15844/pedneurbriefs-19-7-51250Treatment-Continuity of ADHD Compared Using Immediate-Release and Extended-Release MPHJ Gordon Millichap0Northwestern University Feinberg School of MedicineThe continuity of methylphenidate (MPH) therapy for ADHD in young Medicaid beneficiaries (ages 6 to 17 years) treated with immediate-release (IR) or extended-release (ER) MPH formulations was compared in an analysis of statewide California Medicaid claims (2000-2003) conducted at Columbia University, New York; University of Pennsylvania, Philadelphia; and McNeil Pharmaceuticals, Fort Washington, PA.https://www.pediatricneurologybriefs.com/articles/1264methylphenidateimmediate-releaseextended-release
collection DOAJ
language English
format Article
sources DOAJ
author J Gordon Millichap
spellingShingle J Gordon Millichap
Treatment-Continuity of ADHD Compared Using Immediate-Release and Extended-Release MPH
Pediatric Neurology Briefs
methylphenidate
immediate-release
extended-release
author_facet J Gordon Millichap
author_sort J Gordon Millichap
title Treatment-Continuity of ADHD Compared Using Immediate-Release and Extended-Release MPH
title_short Treatment-Continuity of ADHD Compared Using Immediate-Release and Extended-Release MPH
title_full Treatment-Continuity of ADHD Compared Using Immediate-Release and Extended-Release MPH
title_fullStr Treatment-Continuity of ADHD Compared Using Immediate-Release and Extended-Release MPH
title_full_unstemmed Treatment-Continuity of ADHD Compared Using Immediate-Release and Extended-Release MPH
title_sort treatment-continuity of adhd compared using immediate-release and extended-release mph
publisher Pediatric Neurology Briefs Publishers
series Pediatric Neurology Briefs
issn 1043-3155
2166-6482
publishDate 2005-07-01
description The continuity of methylphenidate (MPH) therapy for ADHD in young Medicaid beneficiaries (ages 6 to 17 years) treated with immediate-release (IR) or extended-release (ER) MPH formulations was compared in an analysis of statewide California Medicaid claims (2000-2003) conducted at Columbia University, New York; University of Pennsylvania, Philadelphia; and McNeil Pharmaceuticals, Fort Washington, PA.
topic methylphenidate
immediate-release
extended-release
url https://www.pediatricneurologybriefs.com/articles/1264
work_keys_str_mv AT jgordonmillichap treatmentcontinuityofadhdcomparedusingimmediatereleaseandextendedreleasemph
_version_ 1725158665455927296

Similar Items